Stablepharma is launching the world’s first fridge-free vaccine for the prevention of Tetanus and Diphtheria (SPVX02)Stablepharma is attending Bio-Spring Europe this week, connect with our team using the partneringONE app!
The Reality
A child dying every 20 seconds is an unacceptable statistic. Stablepharma is The Fridge-Free Vaccine Company, committed to launching the world’s first fridge-free vaccines, eliminating the need for the cold chain and enabling stockpiling anywhere in the world.
Fridge-Free Vaccines
Our novel patented StablevaX™ technology is designed to dramatically enhance the performance of existing and new vaccines, thermally stabilise and deliver a wide range of vaccines without the requirement for refrigeration.
Expanding Access
Stablepharma’s fridge-free vaccines can help expand access to patients and increase the success of immunisation programmes.
Latest Press Coverage on Stablepharma
Stablepharma Technology
StablevaX™ is a patented product that aims for enhanced thermostability, following WHO protocols
Zero Refrigeration
StablevaX™ technology aims to eliminate the need for refrigeration
Thermostable Vaccines
StablevaX™ technology is designed with the aim of administering to patients without any change to current practice
We use our StablevaX™ technology to reformulate and thermo-stabilise existing and new vaccines in partnership with vaccine manufacturers. Through this, we eliminate the need for the cold-chain, reduce wastage, costs and carbon emissions. To find out more:
